CN Patent
CN113272290A — 用于沃塞洛托合成的方法和中间体
Assigned to Curia Spain SA · Expires 2021-08-17 · 5y expired
What this patent protects
本发明涉及用于按照以下方案(式(1))制备沃塞洛托或其盐或溶剂化物的方法。
USPTO Abstract
本发明涉及用于按照以下方案(式(1))制备沃塞洛托或其盐或溶剂化物的方法。
Drugs covered by this patent
- Oxbryta (voxelotor) · Global Blood Theraps
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.